June 09, 2016 TOULOUSE, France–(BUSINESS WIRE)– Regulatory News EXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced the strengthening of its executive team with the appointments of: Sébastien Lemoine as VP International Sales and Market Development and François Cathelineau as VP […]